Jakob M. Domm
London, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Corrigendum to "Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing" [2021 Sep-Oct;134(1-2):117-131].
Journal: Molecular genetics and metabolism
Published: February 27, 2023
A promoterless AAV6.2FF-based lung gene editing platform for the correction of surfactant protein B deficiency.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 17, 2023
Treatment-Resistant Wide-Complex Tachycardia in a Three-Year-Old Girl.
Journal: Cureus
Published: January 12, 2022
A palpable chest wall mass in a 4-year-old boy.
Journal: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada
Published: April 08, 2021
Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing.
Journal: Molecular genetics and metabolism
Published: March 09, 2021
Optimized Pre-Clinical Grade Production of Two Novel Lentiviral Vector Pseudotypes for Lung Gene Delivery.
Journal: Human gene therapy
Published: February 01, 2020
A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency.
Journal: Nature communications
Published: July 31, 2019
AAV-Mediated Gene Delivery to the Lung.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 21, 2019
A Novel Triple-Mutant AAV6 Capsid Induces Rapid and Potent Transgene Expression in the Muscle and Respiratory Tract of Mice.
Journal: Molecular therapy. Methods & clinical development
Published: March 27, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026